Skip to main content
MDLN
NASDAQ Industrial Applications And Services

Medline Q3 Sales Up 10.4% to $7.9B; Raises Organic Sales Guidance and Authorizes $1B Buyback

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$37.15
Mkt Cap
$44.818B
52W Low
$31.37
52W High
$50.876
52W Position info
18% above low
Off High info
27% below high
Rel. Volume info
1.8× avg
Market data snapshot near publication time

MDLN sits 18% above its 52-week low of $31.37.

Summary

Medline grew Q3 sales 10.4% to $7.9 billion and raised full-year organic sales guidance, while nine-month net income fell 28.8% on Tracy fire costs. The board also authorized a $1 billion buyback and the company prepaid $750 million of debt.


Key Events · Earnings and Guidance · MDLN

  • Q3 Sales Up 10.4% to $7.9B

    Third quarter net sales rose to $7,856 million from $7,115 million, with Organic Sales up 10.5%. Q3 net income slipped 1.2% to $318 million and Adjusted EBITDA rose 11.8% to $960 million.

  • Full-Year Organic Sales Guidance Raised

    2026 Organic Sales growth outlook lifted to 10.0%-10.5% from 9.0%-10.0%; Adjusted EBITDA guidance of $3.3 billion to $3.4 billion reaffirmed and excludes $324 million of net IEEPA tariff refunds booked in the first nine months.

  • $1B Buyback and $750M Debt Prepayment

    Board authorized repurchases of up to $1 billion of Class A common stock and/or Medline Holdings units; the company also prepaid $750 million of the 2033 Refinancing Term Loan Facility. Net leverage stood at 2.5x on $9.1 billion of net debt.

  • Nine-Month Net Income Down 28.8%

    Net income fell to $696 million from $977 million, including $316 million of net losses related to the Tracy, California distribution center fire, plus higher tariff-related cost of goods and inventory inflation. Free cash flow was $1.8 billion.


Analysis · MDLN · Industrial Applications And Services

Sales growth is holding at double digits, and management lifted the full-year organic sales range to 10.0%-10.5% from 9.0%-10.0% while keeping the $3.3B-$3.4B Adjusted EBITDA outlook. The profit picture is messier: nine-month net income fell 28.8% to $696 million, dragged by $316 million of net losses from the Tracy distribution center fire, higher tariff-laden cost of goods and inflation in inventory costs. Against that, the board authorized up to $1 billion of buybacks and the company prepaid $750 million of its 2033 term loan, which tells you cash generation ($1.8 billion of free cash flow in nine months) is strong enough to fund both. For a company that has spent the past month dealing with FDA warnings on its branded beds and a securities-fraud investigation, the capital-return and debt-reduction moves are the more consequential part of this release.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, MDLN was trading at $37.15 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $44.8B. The 52-week trading range was $31.37 to $50.88. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

MDLN - Latest Insights

MDLN
Nov 18, 2026, 4:34 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $39.16
Real-time Price: $39.69 info
Change: +$0.530 (+1%) info
Market Cap: $51.521B info
MDLN
Nov 17, 2026, 10:23 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $37.51
Real-time Price: $39.69 info
Change: +$2.18 (+6%) info
Market Cap: $51.521B info
MDLN
Nov 16, 2026, 6:42 AM EST
Filing Type: S-1
Importance Score:
8
Price at Filing: $39.24
Real-time Price: $39.69 info
Change: +$0.4526 (+1%) info
Market Cap: $51.521B info
MDLN
Nov 13, 2026, 4:58 PM EST
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $39.82
Real-time Price: $39.69 info
Change: -$0.1259 (-0.32%) info
Market Cap: $51.521B info
MDLN
Nov 04, 2026, 4:32 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $40.35
Real-time Price: $39.69 info
Change: -$0.660 (-2%) info
Market Cap: $51.521B info